dexamethasone,axicabtagene ciloleucel
gilead,daiichi sankyo
['pcnsl', 'omg', 'axi-cel', 'lymphoma', 'dexamethasone']
#ash22 axi-cel for cns lymphoma, n=9, orr 78% ,median dor 11 months, grade 3 or higher icans in 33%. many pts are not able to get cart cell therapy if there is cns involvement, hope more studies like this lead to this therapy becoming availble for these pts ! 
MD